Biohaven Announces Pricing Of Public Offering - Quick Facts
(RTTNews) - Biohaven (BHVN) announced the pricing of underwritten public offering of 5,263,158 of its common shares at a price to the public of $47.50 per share. Biohaven has granted the underwriters a 30-day option to purchase up to an additional 789,473 common shares at the public offering price, less underwriting discounts and commissions.
The gross proceeds from the offering are expected to be approximately $250 million. The offering is expected to close on October 2, 2024. Biohaven plans to use the net proceeds for general corporate purposes.
For More Such Health News, visit rttnews.com.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.